Discover

ALZN
Alzamend Neuro Inc
1.46
1 x 1.42
1 x 1.45
bid
ask
+
0.00
0.00%
01:37 PM
timesize
Ytd-19.78%
1y-39.17%
1.43
day range
1.47
0.84
52 week range
2.68
Open1.43Prev Close1.46Low1.43High1.47Mkt Cap5.55M
Vol10.20KAvg Vol145.96KEPS-3.87P/E-0.38Forward P/E-0.26
Beta0.16Short Ratio1.03Inst. Own0.94%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0250-d Avg1.24200-d Avg1.681yr Est32.00
Income Statement
Operating Expenses2.87M
Research and Development Expense434.01K
Selling, General and Administrative Expense2.44M
Operating Income-2.87M
Interest Expense150.00
Net Income-2.87M
Net Income Common Stock-2.87M
Net Income Common Stock (USD)-2.87M
Consolidated Income-2.87M
Earnings per Basic Share-0.74
Earnings per Basic Share (USD)-0.74
Earnings per Diluted Share-0.74
Earning Before Interest & Taxes (EBIT)-2.87M
Earning Before Interest & Taxes (USD)-2.87M
Weighted Average Shares3.98M
Weighted Average Shares Diluted3.98M
Balance Sheet
Cash and Equivalents710.69K
Cash and Equivalents (USD)710.69K
Current Assets1.76M
Property, Plant & Equipment Net314.87K
Total Assets2.08M
Current Liabilities1.35M
Total Liabilities1.35M
Accumulated Retained Earnings (Deficit)-67.31M
Shareholders Equity733.21K
Shareholders Equity (USD)733.21K
Assets Non-Current314.87K
Trade and Non-Trade Payables1.35M
Cash Flow
Depreciation, Amortization & Accretion27.69K
Net Cash Flow from Financing794.84K
Net Cash Flow / Change in Cash & Cash Equivalents-2.00M
Issuance (Purchase) of Equity Shares794.84K
Net Cash Flow from Operations-2.80M
Share Based Compensation623.81K